Results for tag: "Osteonecrosis Drug"

The Osteonecrosis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteonecrosis is a condition in which bone tissue dies due to lack of blood supply. It is most commonly caused by trauma, but can also be caused by certain medical conditions or medications. Osteonecrosis drugs are used to treat the condition and prevent further damage. These drugs can be divided into two categories: bisphosphonates and calcitonin. Bisphosphonates are used to reduce bone resorption and calcitonin is used to reduce pain and inflammation. The Osteonecrosis Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies such as Eli Lilly, GlaxoSmithKline, and Sanofi also have a presence in the market. Show Less Read more